Infectious
bacterial biofilms are recalcitrant to most antibiotics
compared to their planktonic version, and the lack of appropriate
therapeutic strategies for mitigating them poses a serious threat
to clinical treatment. A ternary heterojunction material derived from
a Bi-based perovskite–TiO2 hybrid and a [Ru(2,2′-bpy)2(4,4′-dicarboxy-2,2′-bpy)]2+ (2,2′-bpy,
2,2′-bipyridyl) as a photosensitizer (RuPS) is developed. This
hybrid material is found to be capable of generating reactive oxygen
species (ROS)/reactive nitrogen species (RNS) upon solar light irradiation.
The aligned band edges and effective exciton dynamics between multisite
heterojunctions are established by steady-state/time-resolved optical
and other spectroscopic studies. Proposed mechanistic pathways for
the photocatalytic generation of ROS/RNS are rationalized based on
a cascade-redox processes arising from three catalytic centers. These
ROS/RNS are utilized to demonstrate a proof-of-concept in treating
two elusive bacterial biofilms while maintaining a high level of biocompatibility
(IC50 > 1 mg/mL). The in situ generation
of radical species (ROS/RNS) upon photoirradiation is established
with EPR spectroscopic measurements and colorimetric assays. Experimental
results showed improved efficacy toward biofilm inactivation of the
ternary heterojunction material as compared to their individual/binary
counterparts under solar light irradiation. The multisite heterojunction
formation helped with better exciton delocalization for an efficient
catalytic biofilm inactivation. This was rationalized based on the
favorable exciton dissociation followed by the onset of multiple oxidation
and reduction sites in the ternary heterojunction. This together with
exceptional photoelectric features of lead-free halide perovskites
outlines a proof-of-principle demonstration in biomedical optoelectronics
addressing multimodal antibiofilm/antimicrobial modality.